Combination Products: Navigating Two FDA Quality Systems

A white paper by Dr. Steven Richter, Ph. D, Microtest

While combination products are experiencing dramatic growth, the convergence of drugs/biologics and devices brings a host of regulatory challenges. Manufacturers must ensure their products meet cGMP practices as well as pass muster with the FDA, ISO, and USP. Dr. Steven Richter of Microtest Labs addresses the critical issues associated with this complex process, including defining the FDA’s regulatory framework, reviewing new developments in FDA thinking, and identifying future considerations in developing effective quality assurance systems.

To download the paper, please fill out the form below. (Microtest respects your privacy. We will not give your email address to third parties or send you unwanted email.)
First Name:
Last Name:
Company:
Street Address:
City:
State or Province: US & Canada only
Zip Code:
Country:
Phone Number:
Email:

©2009 MicroTest Laboratories, Inc. All rights reserved.
Web site designed by Tiziani Whitmyre Inc. - www.tizinc.com